In hematopoietic malignancies, HCSCs (also known as leukemia stem cells, LSCs) have been identified in acute myeloid leukemia (AML) in the 1990s, with specific markers such as CD34+/CD38− [45, 106]. This evidence concerns the gene CD34 and acute myeloid leukemia.